Analysts: Astellas Pharma Inc (4503.T)

4503.T on Tokyo Stock Exchange

1,950JPY
27 Mar 2015
Change (% chg)

¥-28 (-1.39%)
Prev Close
¥1,978
Open
¥1,948
Day's High
¥1,988
Day's Low
¥1,932
Volume
7,027,800
Avg. Vol
7,668,140
52-wk High
¥2,047
52-wk Low
¥1,062

Search Stocks

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform 12.26 March 28 Mar 2015

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 5 5 5 5
(2) OUTPERFORM 6 7 6 5
(3) HOLD 4 3 5 6
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 1.93 1.87 2.00 2.06

Consensus Estimates Analysis

Sales and Profit Figures in Japanese Yen (JPY)
Earnings and Dividend Figures in Japanese Yen (JPY)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Mar-15 2 286,714.00 303,428.00 270,000.00 --
Year Ending Mar-15 14 1,250,150.00 1,350,700.00 1,207,000.00 1,230,220.00
Year Ending Mar-16 14 1,348,030.00 1,416,200.00 1,288,000.00 1,316,410.00
Earnings (per share)
Quarter Ending Mar-15 2 12.26 17.60 6.92 --
Year Ending Mar-15 15 71.63 88.50 58.79 60.44
Year Ending Mar-16 15 89.19 100.00 80.10 72.49
LT Growth Rate (%) 2 22.80 24.70 20.90 23.10

Historical Surprises

Sales and Profit Figures in Japanese Yen (JPY)
Earnings and Dividend Figures in Japanese Yen (JPY)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Dec-14 355,547.00 358,319.00 2,772.00 0.78
Quarter Ending Sep-14 324,800.00 299,296.00 25,504.00 7.85
Quarter Ending Jun-14 292,307.00 295,157.00 2,850.00 0.98
Quarter Ending Dec-13 312,400.00 330,703.00 18,303.00 5.86
Quarter Ending Sep-13 273,900.00 280,854.00 6,954.00 2.54

Consensus Estimates Trend

Sales and Profit Figures in Japanese Yen (JPY)
Earnings and Dividend Figures in Japanese Yen (JPY)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Mar-15 286,714.00 286,714.00 286,714.00 270,000.00 --
Year Ending Mar-15 1,250,150.00 1,250,150.00 1,233,940.00 1,230,020.00 1,230,220.00
Year Ending Mar-16 1,348,030.00 1,348,030.00 1,336,060.00 1,325,960.00 1,316,410.00

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Mar-15 0 0 0 0
Year Ending Mar-15 0 0 5 0
Year Ending Mar-16 0 0 4 1
Earnings

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: ValuEngine, Inc.
$25.00
Provider: ValuEngine, Inc.
$49.00
Provider: Reuters Investment Profile
$20.00
Provider: Wright Reports
$75.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks